Hearing Loss Charity-funded

RNID

Research funded by RNID

Funded awards
350
Published funding
£21.4M
Average published award
£61K
Active funded awards
22
Search funded awards from RNID →

RNID funds most in Brain & Nervous System — 120 grants (34%). Its largest recipient is University College London, with 77 grants.

Funded Awards by Year

View data table
YearFunded awards
20067
20076
20084
200923
201025
201120
20128
201334
201445
201529
201622
201730
20189
201910
202013
202116
202212
20239
202411
202516

Grants

Developing gene therapy to treat progressive hearing loss in Norrie DiseaseUniversity College LondonRNID£300K2023Active
Development of Nanoparticle Antibiotic Adjuvant for the Treatment of Chronic Suppurative Otitis MediaUniversity of StanfordRNID£299K2021Completed
In vivo testing of candidate compounds for protection from aminoglycoside ototoxicityUniversity of SussexRNID£296K2017Completed
Optimization and pharmacokinetics of allele-specific antisense oligonucleotide therapy for late-onset sensorineural hearing impairment DFNA9Radboud University Medical CenterRNID£295K2022Completed
Pharmacological manipulation of neuronal oscillations in tinnitus: bridging the therapeutic gapNewcastle UniversityRNID£295K2015Completed
Patient-specific electrophysical and psychophysical characterisation of cochlear implant hearing for enhancement of pitch perceptionUniversity of CambridgeRNID£225K2026Active
Achieving high temporal and spatial precision with analogue optical cochlear implantsBionics InstituteRNID£221K2025Active
Exploration of novel inflammatory targets in vestibular schwannoma related hearing loss and tinnitusUniversity of BirminghamRNID£217K2025Active
STILLER: Silencing Tinnitus by Individualised Low-Level stimulation to Enhance ResponsesUniversity of AntwerpRNID£215K2025Active
Development of tools to assess and improve the functionality of regenerated ribbon synapsesJohns Hopkins MedicineRNID£200K2024Active
Discovering new aminoglycosides to alleviate inner ear toxicityStanford UniversityRNID£200K2022Completed
Persistent stress granules and the NLRP3 Inflammasome: their roles in hair cell death during ototoxicityUniversity College LondonRNID£200K2024Active
SMarTTER HeAR: Synergising Markers, Tests and Technologies to Enable Real-world Hearing in Alzheimer's and Related dementiasUniversity College LondonRNID£200K2022Completed
Understanding the impact of noise exposure on age-related hearing lossUniversity of SheffieldRNID£199K2022Completed
Preclinical development of antisense oligonucleotide therapy for RIPOR2-associated adultonset hearing lossRadboud University Medical CenterRNID£194K2022Completed
Non-invasively re-training the tinnitus brain using bimodal electrical-sound stimulationTrinity College DublinRNID£194K2024Active
Development of an ultra-efficient dual AAV intein-based gene therapy for children with congenital hearing loss due to otoferlin deficiencyKU LeuvenRNID£188K2024Completed
Unveiling molecular mechanisms and brain networks underlying the link between hearing loss and cognitive decline.Università Cattolica del Sacro CuoreRNID£150K2024Active
Investigating the role of mitonuclear interactions in determining susceptibility of auditory tissues to cisplatin.King's College LondonRNID£150K2025Active
Targeted neurofeedback training to alleviate tinnitus distressUniversity of Illinois Urbana-ChampaignRNID£149K2025Active

Page 1 of 3